AI Article Synopsis

  • Tau pathology in Alzheimer's Disease (AD) spreads sequentially from the entorhinal cortex to the hippocampus and surrounding areas, classified into six "Braak stages."
  • Emerging evidence suggests that Tau propagation may involve transmission through small extracellular vesicles called exosomes, though the specific mechanisms are still unclear.
  • The study demonstrates that exosomes from neurons containing Tau are released during neuron activity, facilitate Tau transfer between neurons, and can induce aggregation of Tau in other cells, indicating a potential avenue for AD progression.

Article Abstract

Background: Tau pathology in AD spreads in a hierarchical pattern, whereby it first appears in the entorhinal cortex, then spreads to the hippocampus and later to the surrounding areas. Based on this sequential appearance, AD can be classified into six stages ("Braak stages"). The mechanisms and agents underlying the progression of Tau pathology are a matter of debate. Emerging evidence indicates that the propagation of Tau pathology may be due to the transmission of Tau protein, but the underlying pathways and Tau species are not well understood. In this study we investigated the question of Tau spreading via small extracellular vesicles called exosomes.

Methods: Exosomes from different sources were analyzed by biochemical methods and electron microscopy (EM) and cryo-EM. Microfluidic devices that allow the culture of cell populations in different compartments were used to investigate the spreading of Tau.

Results: We show that Tau protein is released by cultured primary neurons or by N2a cells overexpressing different Tau constructs via exosomes. Neuron-derived exosomal Tau is hypo-phosphorylated, compared with cytosolic Tau. Depolarization of neurons promotes release of Tau-containing exosomes, highlighting the importance of neuronal activity. Using microfluidic devices we show that exosomes mediate trans-neuronal transfer of Tau depending on synaptic connectivity. Tau spreading is achieved by direct transmission of exosomes between neurons. In organotypic hippocampal slices, Tau-containing exosomes in conditioned medium are taken up by neurons and microglia, not astrocytes. In N2a cells, Tau assemblies are released via exosomes. They can induce inclusions of other Tau molecules in N2a cells expressing mutant human Tau. We also studied exosomes from cerebrospinal fluid in AD and control subjects containing monomeric and oligomeric Tau. Split-luciferase complementation reveals that exosomes from CSF can promote Tau aggregation in cultured cells.

Conclusion: Our study demonstrates that exosomes contribute to trans-synaptic Tau transmission, and thus offer new approches to control the spreading of pathology in AD and other tauopathies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237256PMC
http://dx.doi.org/10.1186/s13024-016-0143-yDOI Listing

Publication Analysis

Top Keywords

tau
19
tau pathology
12
n2a cells
12
exosomes
11
transmission tau
8
tau protein
8
tau spreading
8
microfluidic devices
8
tau-containing exosomes
8
release trans-synaptic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!